HUM

Humana reported Q3 2026 earnings per share of 2.59 SEK on revenue of 2,595 million SEK, keeping its net margin at 1.8%. The share price stayed flat, reflecting market uncertainty about the company’s thin profitability.

Humana’s premiums and Medicare Advantage growth are helping the company, but rising benefit costs and expenses are creating challenges.

Humana formed a joint venture with HPS Investment Partners to manage about 150 CenterWell senior primary care clinics, with BlackRock acquiring a $2.8 billion equity stake. The deal reduces Humana’s balance sheet liabilities and provides fresh capital for clinic expansion.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

When Humana sends a plan-exit notice this fall, most members will scan it for a replacement option and move on. But buried in that letter is a federal right with an expiration date that could matter far more than any plan Humana offers instead.

Humana’s CenterWell venture with BlackRock brings $2.8 billion in capital, easing balance sheet liabilities and supporting clinic expansion.

LATHAM, N.Y., October 14, 2026--AngioDynamics, Inc.